Nalaganje...
Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
PURPOSE: Among a cohort of postmenopausal breast cancer survivors, we aimed to compare the risk of dementia associated with aromatase inhibitor (AI) therapy versus tamoxifen. METHODS: Using UK primary care electronic health records, we identified 14,214 postmenopausal breast cancer survivors (aged ≥...
Shranjeno v:
| izdano v: | J Cancer Surviv |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6776493/ https://ncbi.nlm.nih.gov/pubmed/31321612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11764-019-00782-w |
| Oznake: |
Označite
Brez oznak, prvi označite!
|